CompaniesJina Pharmaceuticals

Jina Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (8)
View all

Total Trials

8

As Lead Sponsor

6

As Collaborator

2

Total Enrollment

1,700

By Phase

PHASE2: 3PHASE3: 4PHASE1: 1

By Status

NOT_YET_RECRUITING: 3COMPLETED: 2ACTIVE_NOT_RECRUITING: 1RECRUITING: 1SUSPENDED: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT00329498
NCT03671044
Hover over trial bars to see details

Recent Trials

NCT06890832Lead Sponsor
A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer
PHASE2Not yet recruiting
75 participants
Started: May 31, 2025 · Completed: Jun 30, 2027
NCT06867042Lead Sponsor
Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment
PHASE2Not yet recruiting
150 participants
Started: Apr 30, 2025 · Completed: Apr 30, 2026
NCT06867562Lead Sponsor
Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer
PHASE3Not yet recruiting
166 participants
Started: Apr 30, 2025 · Completed: Mar 31, 2026
NCT06608641Lead Sponsor
Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients
PHASE3Active, not recruiting
490 participants
Started: Mar 19, 2024 · Completed: Dec 31, 2025
NCT04315792Lead Sponsor
Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients
PHASE3Completed
124 participants
Started: Aug 3, 2020 · Completed: Aug 25, 2021
View all 8 trials →